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Abstract
Objectives: To present the demographic data, clinico-pathologic features and therapeutic outcome of a series of 
upper lip malignancies. 
Study Design:  Retrospective study at a single Cancer Institution in Mexico City during a 14-year period.
Results: There were 59 cases, (30 males and 29 females); age range: 14 to 106 years (mean: 73 yr.). Antecedents 
of ultraviolet light and tobacco exposure were found in 20 (33.9%) and 16 cases (27%) respectively. There were 
35 squamous cell carcinomas (59.3%), 19 basal cell carcinomas (32.2%) and one case each (1.7%) of adenocarci-
noma NOS, adenoid cystic carcinoma, angiosarcoma, Merkel cell carcinoma and melanoma.  There were 14 cases 
in stage I (23.7%), 14 in stage II (23.7%), 3 in stage III (5.1%) 14 in stage IV (23.7%) and 14 were not classified 
(23.7%). There were no significant differences with respect to the overall survival curve and the disease-free sur-
vival curve among surgical treatment and radiotherapy. In addition, there was not statistically significant differ-
ence in the overall survival and disease-free survival among squamous cell carcinoma and basal cell carcinoma 
cases with respect to the type of treatment. 
Conclusions: Upper lip malignant neoplasms are infrequent lesions. The present series describes the main clinico-
pathological features in a hospital-based population in Mexico city and demonstrates some differences with re-
spect to those found in the lower lip.
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Introduction
Malignant neoplasms of the upper lip are relatively in-
frequent lesions as compared to those found in the lower 
lip (1-3). Although squamous cell carcinoma (SCC) is 
the most frequent cancer of the lower lip and show a 
male predominance, basal cell carcinoma (BCC) tend 
to be most frequent in the upper lip, and in this location 
cancer incidence is similar for both genders or it is even 
higher in female patients (4).
The aim of this study is to present the demographic 
data, clinico-pathologic features and therapeutic out-
come of the upper lip malignant neoplasms diagnosed 
in a single Cancer Institution in Mexico City during an 
11-year period.
Material and Methods
We reviewed the clinical records of the patients with 
upper lip cancer that were admitted at the Instituto 
Nacional de Cancerología (México) between 1990 and 
2000. Demographic data included age, gender, type 
of occupation (related or not to ultraviolet light expo-
sure), and tobacco smoking antecedents. In addition, 
relevant data about time of evolution, histopathological 
diagnosis, type of treatment, recurrence or persistence 
of the disease, follow-up, and current status of each 
patient were recorded. Both primary and recurrent le-
sions that developed in the upper lip were included in 
this study. We accepted as recurrence those lesions that 
presented the same histology as the original tumor and 
involved the primary site or regional lymph nodes and 
were detected after 6 months of having completed the 
treatment; the presence of the disease before this period 
was considered persistence. Likewise, we recorded the 
secondary treatment performed in each case. 
The disease was classified according to its histology. In 
cases of squamous cell carcinoma the grading system 
of the classification proposed by Broders (5) was used. 
Clinical stage was determined according to the Ameri-
can Joint Committee on Cancer (AJCC), and location 
of the tumor was stated as upper lip; the lip was in turn 
divided in three sub-sites or thirds: central, left and 
right, according to the site of origin of the tumor. The 
presence of regional lymph node involvement, as well 
as distant metastases both at the time of admittance and 
during the course of treatment were recorded.   
Statistical evaluation was performed by means of Chi-
square and Student’s t tests, and those statistically sig-
nificant differences were subjected to Cox multivariate 
analysis. Survival was assessed through the Kaplan and 
Meier curve. All tests were assessed at a confidence 
interval of 95%, and statistical significance was set at 
p<0.05.
Results
There were 59 cases of upper lip malignancies. Of 
these, 30 (50.8%) occurred in males and 29 (49.2%) in 
females, with an age range from 14 to 106 years (mean: 
73 yr.). The salient clinical and demographic features 
are shown in table 1. Histopathologic diagnosis and his-
tological grading are shown in table 2, where it is shown 
that although SCC and BCC carcinomas accounted for 
more than 90% of the cases, there were five other diffe-
n  (%) 
Gender Female 
Male 
29 (49.2) 
30 (50.8) 
Sun exposure antecedent YesNo
Not stated 
20 (33.9) 
28 (47.5) 
11 (18.6) 
Tobacco smoke YesNo
Not stated 
16 (27) 
36 (61) 
7 (12) 
Previously treated in another 
institution 
Yes
No
9 (15) 
50 (85) 
T
1
2
3
4
Not classified 
15 (25.4) 
16 (27.1) 
3 (5.1) 
11 (18.6) 
14 (23.7) 
N
0
1
2
Not classified 
37 (62.7) 
5 (8.5) 
3 (5.1) 
14 (23.7) 
Stage 
I
II
III
IV
Not classified 
14 (23.7) 
14 (23.7) 
3 (5.1) 
14(23.7) 
14 (23.7) 
Table 1. Clinical and demographic features of upper lip malig-
nancies in the present series.
Histological diagnosis n   (%) 
Squamous cell carcinoma 
            - Well differentiated 
            -  Moderately differentiated  
            -  Poorly differentiated 
             
Basal cell carcinoma                     
Adenocarcinoma                           
Melanoma                                     
Adenoid cystic carcinoma            
Merkel cell carcinoma                       
Angiosarcoma                                    
35 (59.3) 
24 (68.5) 
  9 (25.7) 
  2 (5.7) 
19 (32.2) 
  1 (1.7) 
  1 (1.7) 
  1 (1.7) 
  1 (1.7) 
  1 (1.7) 
Table 2. Histopathologic features of upper lip malignan-
cies in the present series.
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rent malignant neoplasms diagnosed.  Only 46 patients 
were treated, and there were 4 recurrences (8.7%) and 
13 persistent cases (28.3%), comprising a total of 17 
cases (36.9%). Comparison among surgical treatment vs 
radiotherapy is shown in table 3. The fig. 1 illustrates the 
overall survival curve (A) and the disease-free period 
(B). The fig. 2 show the overall survival curve (A) and 
the disease free period (B) according to primary treat-
ment, and it was found that there were no significant 
differences with respect to the overall survival curve 
and the disease-free survival curve among both types of 
treatment (p=0.4947 and p=0.7492 respectively). In addi-
tion, there was not statistically significant difference in the 
overall survival (p=0.66) and disease-free survival (p=0.50) 
 Surgery 
n=17 (%) 
Radiotherapy 
n=29 (%) p
Sun exposure 
Yes
No
Unknown
6 (35.3) 
9 (52.9) 
2 (11.8) 
12 (41.4) 
11 (37.9) 
6 (20.7) 
0.403 
Tobacco smoking 
Yes
No
Unknown 
4 (23.5) 
11 (64.7) 
2 (11.8) 
9 (31) 
15 (51.7) 
5 (17.2) 
0.648 
Histologic subtypes 
Squamous cell carcinoma 
Basal cell carcinoma 
Melanoma
Adenoid cystic carcinoma 
Angiosarcoma
Adenocarcinoma 
Merkel cell carcinoma 
10 (58.8) 
4 (23.5) 
1 (5.9) 
1 (5.9) 
1 (5.9) 
0
0
15 (51.7) 
12 (41.4) 
0
0
0
1 (3.4) 
1 (3.4) 
0.234 
0.350 
Clinical stage 
I
II
III
IV
Not classified  
5 (29.4) 
3 (17.6) 
0
1 (5.9) 
8 (47.1) 
6 (20.7) 
9 (31) 
3 (10.3) 
8 (27.6) 
3 10.3) 
0.174 
Histological grade 
Well differentiated 
Moderately differentiated 
Poorly differentiated 
Not evaluated 
5 (29.5) 
4 (23.5) 
1 (5.9) 
7 (41.2) 
10 (34.5) 
4 (13.8) 
2 (6.9) 
13 (44.8) 
0.426 
Recurrence 8 (47.1) 9 (31) 0.125 
Table 3. Distribution according to treatment modalities.
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Fig. 1. A. Overall survival curve of the present series. B. Disease-free period of the present series. 
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Fig. 2. A. Overall survival curve according to primary treatment, B. Disease free period according to primary treatment.
Fig. 3. A. Advanced BCC of the upper lip in a 55 year-old 
male patient in which the site of origin cannot be determined. 
B. Primary cutaneous BCC with early invasion to the vermil-
ion border in a 66 year-old female patient.
Discussion 
The site of origin of lip tumors seems to be related to 
their histologic subtype and possible etiological factors, 
as it has been found that SCC is the most common ma-
lignant neoplasm of the lower lip, which is more suscep-
tible to sun-induced carcinogenic damage, while BCC 
predominates in the upper lip, usually as a consequence 
of penetration from a neoplasm originated in the adja-
cent skin epithelium; there are also differences between 
gender distribution with respect to location, some au-
thors have pointed out that BCC of the upper lip has a 
predilection to occur in females (4,6-8).  In one Canadi-
an study it has been reported that females, particularly 
young women outnumbered males with basal cell car-
cinoma of the upper lip, which contrasts with BCC s´ di-
agnosed in other sites in the same population, in which 
males outnumber females (4).  In this study, there were 
an almost equal number of upper lip malignancies in 
both genders, with a slight male predominance, which 
may be explained by the fact that the majority of tumors 
were SCC s´  (59.3%) and that most patients affected by 
SCC had a positive antecedent of sun exposure (33.9%) 
and tobacco consumption (27%), which are the most 
important etiologic factors implicated in the origin of 
this neoplasm, and they were more frequent in males in 
the present series, although there were not significant 
differences for sun exposure and tobacco consumption 
respectively. Although the possible reason of the higher 
susceptibility of the lower lip to SCC in older age may 
lie in the fact that during the aging process the inter-
maxillary distance is progressively reduced as a con-
sequence of teeth wear, resulting in a protrusion of the 
lower vermilion border, which is therefore more suscep-
tible to the action of these carcinogens, this explanation 
is not valid for SCC of the upper lip. There was however, 
a significant number of patients that consumed tobacco 
among squamous cell carcinoma and basal cell carcinoma 
cases with respect to the type of treatment (p=0.347).  
The fig. 3 illustrate two cases in which there is some dif-
ficulty to define the exact anatomical site of origin (skin 
or mucosa) of the upper lip basal cell carcinoma, which 
usually is not a problem in the case of lower lip SCC. 
A
B
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in this group, which may be an important carcinogenic 
agent to be considered in these cases. 
Some studies have suggested that upper lip malignant 
epithelial neoplasms could derive from pluripotential 
epithelial cells of the oral mucosa and epidermis (8). 
Other authors consider their origin from ectopic se-
baceous glands (9). On this respect, the incidence of 
Fordyce granules (ectopic sebaceous glands) tend to in-
crease with advancing age, and these are normally de-
tected in the lips and oral mucosa in a high percentage 
of senior adults in Western populations (10); however, 
primary malignant sebaceous tumors in these regions 
are exceedingly rare (11). Against the hypothesis of an 
origin of BCC from these glands is the fact that Fordyce 
granules are more frequent in males (12), contrary to 
the reported higher incidence of BCC seen in female pa-
tients in some series. The other possibility of origin may 
be from traumatic epithelial implantation (13). To date, 
there is not a satisfactory explanation about the possi-
ble etiologic factors implicated in the origin of BCC of 
the vermillion and mucosal surfaces of the lips, except 
for those cases that secondarily invade these structures 
from adjacent skin. 
An important question here is to know if the site of ori-
gin of BCC of the lip, that is the vermillion or the skin 
surface, makes these neoplasms to be considered as dif-
ferent entities; that is, if they should be considered as 
cutaneous or as oral malignancies, and if such a differ-
ence is a factor that determine their different biological 
behavior, as it has long been known that once a malig-
nant neoplasm extends into the vermillion or the labial 
mucosa surface, particularly in the case of BCC, ac-
quires a more aggressive biological behavior than its cu-
taneous counterpart (Fig. 3). From an oncological point 
of view, we may consider that this separation is not very 
important, as all malignant epithelial neoplasms, when 
located in the lip (vermillion or mucosa), even in their 
earlier stages, tend to invade deep structures, and here 
tumoral invasion is particularly favored by the fact that 
the lamina propria in these anatomical regions is very 
thin and allows the neoplasm to invade nerves and mus-
cles more easily than when the neoplasm is located only 
in the skin, which is a more resistant structure to deep 
neoplastic invasion (8). These facts are important from 
the surgical and functional points of view, as they de-
termine the extent and type of complex reconstructive 
procedures in this anatomical region. 
In our series, 28.8% of the tumors were in advanced 
stages, which is similar to the findings reported by 
Zitsch et al. (3), who found that 25% of their cases lo-
cated in the upper lip were tumors larger than 3 cm, 
but differ from those reported by Leibovitch et al. (6), 
who found that 90% of their cases were smaller than 2 
cm. In the present study it was found that most patients 
were of low socioeconomic level and the lack of symp-
tomatology of the neoplasms in their early stages was 
a definitive factor that caused a delayed diagnosis and 
hence most cases were treated in advanced stages. This 
situation is reflected also in our series in that there were 
4 (8.6%) recurrences and 13 (28.2%) cases that showed 
persistence of the neoplasms, which had to be submitted 
to a new treatment, increasing in this way the functional 
alterations and the aesthetic aspect of the affected indi-
viduals. 
It is interesting to note that in this study, in addition to 
SCC and BCC there were five (8.5%) cases of other ma-
lignant neoplasms. To our knowledge, only isolated case 
reports of these rare tumors affecting the lips have been 
published, and therefore this study may be important to 
determine the relative frequency of these unusual ma-
lignancies as their management should be individual-
ized according to their specific biological behavior. 
In addition, it has to be considered that although there 
are few histologic subtypes of malignant neoplasms that 
tend to affect the upper lip, once cutaneous malignan-
cies reaches the upper lip vermillion border or adjacent 
mucosa, they should be considered a particular type of 
lip neoplasm, as the prognosis is worst in comparison to 
those limited to the adjacent skin. There seems to be no 
differences in terms of survival between cases treated 
with surgery and those with radiotherapy; however, 
from a functional point of view this could be different in 
cases requiring large resections, and therefore surgery 
is problably best indicated in early (small) lesions.
In conclusion, upper lip malignant neoplasms are infre-
quent lesions, the present series describes the main clin-
ico-pathological features in a hospital-based population 
in Mexico city and demonstrates some differences with 
respect to those found in the lower lip.
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